Palbociclib plus exemestane with gonadotropin-releasing hormone agonist versus capecitabine in premenopausal women with hormone receptor-positive, HER2-negative metastatic breast c... by Park, Yeon Hee, Prof, Kim, Tae-Yong, MD, Kim, Gun Min, MD, Kang, Seok Yun, MD, Park, In Hae, MD, Kim, Jee Hyun, Prof, Lee, Kyoung Eun, MD, Ahn, Hee Kyung, MD, Lee, Moon Hee, Prof, Kim, Hee-Jun, MD, Kim, Han Jo, MD, Lee, Jong In, Prof, Koh, Su-Jin, MD, Kim, Ji-Yeon, MD, Lee, Kyung-Hun, MD, Sohn, Joohyuk, Prof, Kim, Sung-Bae, Prof, Ahn, Jin-Seok, Prof, Im, Young-Hyuck, Prof, Jung, Kyung Hae, Prof, Im, Seock-Ah, Prof

Get full text

Palbociclib plus endocrine therapy versus capecitabine in premenopausal women with hormone receptor-positive, HER2-negative metastatic breast cancer (Young-PEARL): overall survival... by Ahn, Hee Kyung, MD, Kim, Ji-Yeon, MD, Lee, Kyung-Hun, Prof, Kim, Gun Min, MD, Kang, Seok Yun, Prof, Lee, Keun Seok, Prof, Kim, Jee Hyun, Prof, Lee, Kyong Eun, Prof, Lee, Moon Hee, Prof, Kim, Hee-Jun, Prof, Kim, Han Jo, Prof, Koh, Su-Jin, MD, Park, In Hae, MD, Sohn, Joohyuk, Prof, Kim, Sung-Bae, Prof, Ahn, Jin Seok, Prof, Kim, Seonwoo, PhD, Cho, Hyun, MSc, Jung, Kyung Hae, Prof, Im, Seock-Ah, Prof, Park, Yeon Hee, Prof

Get full text